SCHEMBL19787915

SCHEMBL19787915

CCc1cnc2[nH]cc(I)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.47
MAPK1 P28482 1/20 0.38
BRAF P15056 1/20 0.36
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 2/20 0.36
CDK8 P49336 2/20 0.35
AXL P30530 1/20 0.35
TNIK Q9UKE5 1/20 0.35
PDPK1 O15530 1/20 0.35
SGK1 O00141 2/20 0.34
CYP3A4 P08684 2/20 0.34
CAMKK2 Q96RR4 1/20 0.34
DYRK1A Q13627 5/20 0.34
CLK1 P49759 4/20 0.34
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
PLK4 O00444 1/20 0.33
AURKA O14965 1/20 0.33
JAK2 O60674 1/20 0.33
ROCK2 O75116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13332909 0.83 BRD4 (0.43) BRD4MAPK1CDK8AXLTNIK
SCHEMBL14032289 0.81 MET (0.42) BRAFAXLPDPK1PRMT5WDR77
SCHEMBL12762846 0.81 CYP3A4 (0.48) BRAFCYP2C9CYP2C19SGK1CYP3A4
SCHEMBL24005713 0.79 PRMT5 (0.40) BRAFCYP2C9CYP2C19AXLPDPK1
SCHEMBL20067661 0.78 CYP3A4 (0.35) CYP2C9CYP2C19AXLPDPK1SGK1
SCHEMBL19286222 0.77 CYP3A4 (0.42) CYP2C9CYP2C19SGK1CYP3A4CAMKK2
SCHEMBL22330343 0.77 PDPK1 (0.36) CYP2C9CYP2C19CDK8AXLTNIK
SCHEMBL25139536 0.77 AXL (0.33) BRAFCYP2C19CDK8AXLTNIK
SCHEMBL1045946 0.77 BRD4 (0.54) BRD4MAPK1CYP2C9CYP2C19CDK8
SCHEMBL31228005 0.77 BRD4 (0.54) BRD4MAPK1CYP2C9CYP2C19CDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873693-B2 Methods of treatment using pyridinonyl PDK1 inhibitors SUNESIS PHARMACEUTICALS, INC. (US) 2018-01-23 US disclosed